Workflow
固态电池粘合剂
icon
Search documents
【金牌纪要库】固态电池粘合剂大换血!原为湿法工艺配备的粘合剂或不再适配固态电池干法工艺,这些企业已开发新型粘合剂产品
财联社· 2025-06-13 01:47
Group 1 - The article highlights a significant shift in solid-state battery adhesive technology, indicating that adhesives originally designed for wet processes may no longer be suitable for the dry processes used in solid-state batteries, prompting companies to develop new adhesive products [1] - The price of sulfide materials for solid-state batteries continues to rise, with high technical barriers, and several companies have identified methods for preparing corresponding sulfide products [1] - Many solid-state battery current collector solutions are moving away from traditional copper and aluminum foils, with stainless steel current collector research and development companies beginning to send samples [1]
创新药概念股走强,海辰药业股价涨停
Zheng Quan Zhi Xing· 2025-05-21 07:36
Group 1 - The A-share innovative drug sector is experiencing renewed activity, with Haitian Pharmaceutical's stock price hitting the daily limit, closing with a transaction amount of 5.03 billion yuan and a turnover rate of 24.22% [1] - The market enthusiasm is driven by multiple industry catalysts, including the global rights cooperation between 3SBio and Pfizer for the PD-1/VEGF bispecific antibody SSGJ-707, highlighting the internationalization trend of domestic innovative drug technology [1] - Haitian Pharmaceutical's strong performance is closely related to its dual business layout, with ongoing advancements in its high-end generic drug R&D pipeline and a new materials segment making breakthroughs through technical cooperation [1] Group 2 - Industry data supports optimistic expectations for the innovative drug sector, with Wanlian Securities reporting strong valuation recovery momentum for domestic innovative drugs driven by policy support and industrial upgrades [2] - According to Frost & Sullivan, the Chinese innovative drug market size has increased from 132.5 billion USD in 2019 to 159.2 billion USD in 2024, maintaining a global market share of around 15% [2] - In 2024, there were 94 licensing transactions in China's innovative drug sector, totaling 51.9 billion USD, a year-on-year increase of 26%, with the first quarter of 2025 continuing this explosive trend with 41 transactions worth 36.9 billion USD [2]